health
BMJ Review Details Advances in Kidney Cancer Care
A BMJ clinical review describes how molecular classification, kidney-sparing treatment and immune-based combinations are shaping renal cell carcinoma care. It highlights improved outcomes in some settings alongside persistent resistance and a lack of validated biomarkers to guide treatment choice.